Abstract
Cost-Effectiveness of Saxagliptin Compared To Glp-1 Analogues As An Add-On To Insulin in the Treatment of Type 2 Diabetes Mellitus From A Uk Health Care Perspective
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have